
BICO Group AB (BICO) - Financial and Strategic SWOT Analysis Review
Description
BICO Group AB (BICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
BICO Group AB (BICO AB) is engaged in the development and marketing of bioprinting technologies which enable researchers to print three dimensional (3D) human organs and tissues. The company’s product portfolio encompasses bioprinters, drug screening, biodispensing solutions and automated non-contact plate washers and liquid dispenser, among others. It also offers spheroOne, the single large-particle sorter and dispenser platform. BICO caters to research institutions, pharmaceutical, biopharmaceutical, automotive, and cosmetic companies. The company sells its products through direct sales force in the US and Sweden and through an extensive network of distributors in Europe (excluding Sweden), and Asia-Pacific. It operates a subsidiary in the US. BICO AB is headquartered in Goteborg, Sweden.
BICO Group AB Key Recent Developments
Jun 25,2025: BICO Group Appoints Lars Risberg as General Counsel
May 23,2025: Chief Operating Officer Marius Balger is leaving BICO
Apr 29,2025: BICO Group Publishes Q1 2025 Interim Report
Feb 19,2025: BICO Group Publishes Year-end report 2024
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
BICO Group AB (BICO AB) is engaged in the development and marketing of bioprinting technologies which enable researchers to print three dimensional (3D) human organs and tissues. The company’s product portfolio encompasses bioprinters, drug screening, biodispensing solutions and automated non-contact plate washers and liquid dispenser, among others. It also offers spheroOne, the single large-particle sorter and dispenser platform. BICO caters to research institutions, pharmaceutical, biopharmaceutical, automotive, and cosmetic companies. The company sells its products through direct sales force in the US and Sweden and through an extensive network of distributors in Europe (excluding Sweden), and Asia-Pacific. It operates a subsidiary in the US. BICO AB is headquartered in Goteborg, Sweden.
BICO Group AB Key Recent Developments
Jun 25,2025: BICO Group Appoints Lars Risberg as General Counsel
May 23,2025: Chief Operating Officer Marius Balger is leaving BICO
Apr 29,2025: BICO Group Publishes Q1 2025 Interim Report
Feb 19,2025: BICO Group Publishes Year-end report 2024
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
55 Pages
- Section 1 - About the Company
- BICO Group AB - Key Facts
- BICO Group AB - Key Employees
- BICO Group AB - Key Employee Biographies
- BICO Group AB - Major Products and Services
- BICO Group AB - History
- BICO Group AB - Company Statement
- BICO Group AB - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- BICO Group AB - Business Description
- Business Segment: Bioautomation
- Overview
- Performance
- Business Segment: Bioprinting
- Overview
- Overview
- Performance
- Business Segment: Biosciences
- Overview
- Performance
- Geographical Segment: Australia
- Performance
- Geographical Segment: Austria
- Performance
- Geographical Segment: Belgium
- Performance
- Geographical Segment: Canada
- Performance
- Geographical Segment: China
- Performance
- Geographical Segment: Denmark
- Performance
- Geographical Segment: Finland
- Performance
- Geographical Segment: France
- Performance
- Geographical Segment: Germany
- Performance
- Geographical Segment: Hong Kong
- Performance
- Geographical Segment: Ireland
- Performance
- Geographical Segment: Israel
- Performance
- Geographical Segment: Italy
- Performance
- Geographical Segment: Japan
- Performance
- Geographical Segment: Netherlands
- Performance
- Geographical Segment: Other
- Performance
- Geographical Segment: Singapore
- Performance
- Geographical Segment: South Korea
- Performance
- Geographical Segment: Spain
- Performance
- Geographical Segment: Sweden
- Performance
- Geographical Segment: Switzerland
- Performance
- Geographical Segment: Taiwan
- Performance
- Geographical Segment: UK
- Performance
- Geographical Segment: USA
- Performance
- R&D Overview
- BICO Group AB - Corporate Strategy
- BICO Group AB - SWOT Analysis
- SWOT Analysis - Overview
- BICO Group AB - Strengths
- BICO Group AB - Weaknesses
- BICO Group AB - Opportunities
- BICO Group AB - Threats
- BICO Group AB - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- BICO Group AB, Medical Equipment, Deals By Year, 2019 to YTD 2025
- BICO Group AB, Medical Equipment, Deals By Type, 2019 to YTD 2025
- BICO Group AB, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Jun 25, 2025: BICO Group Appoints Lars Risberg as General Counsel
- May 23, 2025: Chief Operating Officer Marius Balger is leaving BICO
- Apr 29, 2025: BICO Group Publishes Q1 2025 Interim Report
- Feb 19, 2025: BICO Group Publishes Year-end report 2024
- Nov 26, 2024: BICO Group Releases Interim Report for January - September 2024
- Nov 25, 2024: CELLINK Announces Further Right-Sizing and Launches Sharpened Commercial Agenda
- Aug 20, 2024: Publication of BICO Group Interim report January-June 2024
- Jul 10, 2024: Andréas Joersjö appointed as General Counsel for BICO Group AB
- May 06, 2024: BICO Changes Method for Impairment Test of Goodwill Resulting in Retroactive Impairment of Goodwill for 2022 and 2023 and Provides Preliminary Figures for Q1 2024
- Apr 18, 2024: Anders Fogelberg appointed as Chief Commercial Officer for BICO Group AB (publ
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- BICO Group AB, Key Facts
- BICO Group AB, Key Employees
- BICO Group AB, Key Employee Biographies
- BICO Group AB, Major Products and Services
- BICO Group AB, History
- BICO Group AB, Other Locations
- BICO Group AB, Subsidiaries
- BICO Group AB, Key Competitors
- BICO Group AB, Ratios based on current share price
- BICO Group AB, Annual Ratios
- BICO Group AB, Annual Ratios (Cont...1)
- BICO Group AB, Annual Ratios (Cont...2)
- BICO Group AB, Interim Ratios
- BICO Group AB, Medical Equipment, Deals By Year, 2019 to YTD 2025
- BICO Group AB, Medical Equipment, Deals By Type, 2019 to YTD 2025
- BICO Group AB, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- BICO Group AB, Performance Chart (2020 - 2024)
- BICO Group AB, Ratio Charts
- BICO Group AB, Medical Equipment, Deals By Year, 2019 to YTD 2025
- BICO Group AB, Medical Equipment, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.